Full-Time
Global dental products & technologies provider
$81.4k - $99.4k/yr
Tulsa, OK, USA + 1 more
More locations: Oklahoma City, OK, USA
Remote
Remote in the United States; territory includes Oklahoma and Texas.
Bachelor's
See people who can refer or advise you
Envista provides a comprehensive range of dental products, including implants, orthodontic braces, clear aligners, and digital imaging equipment. These products work together to support nearly 90% of a dentist's clinical needs, from initial digital diagnosis and treatment planning to the physical tools used for surgery and infection prevention. Unlike many competitors that focus on a single niche, Envista offers a massive portfolio of established brands like Nobel Biocare and Ormco that cover both specialized surgery and everyday consumables. The company's goal is to provide dental professionals with a complete, integrated ecosystem of tools and software to improve patient outcomes globally.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Brea, California
Founded
2004
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Performance Bonus
Envista to host Investor Day on September 17, 2026. Jul 28, 2026, 16:15 ET BREA, Calif., July 28, 2026 /PRNewswire/ - Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will hold an Investor Day on Thursday, September 17, from 9:00 a.m. to noon EDT. This event will include a management presentation followed by a question-and-answer session. The event and corresponding presentation will be webcast live and also available for replay afterwards by visiting the Events and Presentations section of investors.envistaco.com. In-person attendance requires advanced registration. Those interested in attending the event in person can contact [email protected] for more information. ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global leader in the dental industry, uniting more than 30 trusted brands - including DEXIS, Kerr, Nobel Biocare, and Ormco - under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care - today and for the future. Learn more at http://envistaco.com. FOR FURTHER INFORMATION Jim Gustafson Vice President, Investor Relations Envista Holdings Corporation 200 S. Kraemer Blvd., Building E Brea, CA 92821 Telephone: (424) 350-5259 [email protected] SOURCE Envista Holdings Corporation
Varsha Jagwani appointed Head of Human Resources, India at Envista Holdings Corporation. Mumbai, Maharashtra, India, July 2026 - Envista Holdings Corporation, a global leader in the dental industry, has appointed Varsha Jagwani as Head of Human Resources - India. In her new role, she will partner closely with the India leadership team to drive the company's people agenda, strengthen organizational capability, build leadership pipelines, and foster a high-performance culture that supports Envista's continued growth in one of its key strategic markets. Varsha joins Envista from Essity, where she served as Human Resource Leader - India, leading the people strategy for the company's commercial organization and manufacturing operations in Goa. She was responsible for aligning HR strategy with business priorities, driving workforce planning, leadership development, succession management, organizational development, employee engagement, performance management, and diversity, equity and inclusion (DEI) initiatives. Her work focused on building future-ready talent capabilities while supporting both commercial and plant operations through strategic people interventions. Before Essity, Varsha spent over seven years with BD (Becton, Dickinson and Company), progressing through roles as Assistant Manager, Deputy Manager, and Human Resources Manager. During her tenure, she partnered with business leaders across talent management, HR business partnering, organizational effectiveness, employee engagement, leadership development, performance management, and workforce planning while supporting business transformation initiatives within the healthcare technology sector. Earlier in her career, she spent nearly six years with Wipro Infotech, where she held HR business partnering responsibilities across the BFSI and Enterprise business verticals, leading initiatives in performance management, employee engagement, talent retention, leadership support, and people development. She began her HR journey with Embee Software Pvt. Ltd., where she gained foundational experience across recruitment, HR operations, employee lifecycle management, engagement, training coordination, and HR administration. Across nearly two decades of HR leadership experience, Varsha has developed deep expertise in HR Strategy, HR Business Partnering, Talent Management, Leadership Development, Workforce Planning, Organizational Development, Succession Planning, Employee Engagement, Performance Management, Diversity, Equity & Inclusion (DEI), Change Management, Culture Transformation, Capability Building, Manufacturing HR, Commercial HR, Employee Relations, and Strategic People Leadership. Her appointment reinforces Envista's commitment to strengthening its leadership capability and people-first culture as the company continues to expand its presence and innovation footprint across India. Envista Holdings Corporation is a global leader in the dental industry, bringing together more than 30 trusted brands, including DEXIS, Kerr, Nobel Biocare, and Ormco, to help dental professionals improve patient outcomes worldwide. The company's portfolio spans dental imaging, diagnostics, implants, orthodontics, treatment technologies, consumables, and digital workflow solutions that support clinicians across every stage of patient care. Built on a legacy of innovation, Envista's brands have pioneered many of modern dentistry's breakthrough technologies - from the world's first dental implant and advanced orthodontic systems to industry-leading imaging platforms and restorative solutions. Guided by its Envista Business System, the company combines continuous improvement, customer-centric innovation, and operational excellence to deliver technologies and services that enable dental professionals to provide efficient, confident, and high-quality care across global markets.
Barclays has reiterated an Overweight rating on Envista Holdings Corporation but lowered its price target to $32 from $34. The dental products manufacturer is among top picks of Ariel Investments. Envista reported strong first-quarter results, with 9.5% core revenue growth translating into 25% adjusted EBITDA growth and 50% earnings-per-share growth. The company delivered growth across all major businesses, driven by customer engagement and new product commercialisation. For the full year, Envista maintained its guidance, expecting sales growth of 2% to 4% and adjusted EBITDA growth of 7% to 13%. The company projects adjusted diluted earnings per share between $1.35 and $1.45. Envista manages a portfolio of over 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company was spun off from Danaher Corporation.
Aristotle Small Cap Equity Fund picked Envista Holdings (NVST) citing varied growth signals. Published on May 21, 2026 at 10:46 am by soumya eswaran in hedge fund investor letters, news. Aristotle Capital Boston, LLC, an investment advisor, released its first-quarter 2026 investor letter for "Small Cap Equity Fund". A copy of the letter is available to download here. U.S. small-cap equities delivered strong performance in the first quarter amid macroeconomic and geopolitical volatility, outpacing large-cap stocks. Improving earnings, attractive relative valuations, and a focus on domestic sectors supported the small caps in the quarter. In this backdrop, the Aristotle Small Cap Equity Fund (Class I-2) delivered a total return of 1.50% in the quarter, outperforming the Russell 2000 Index's 0.89% return. The performance was supported by security selection in the information technology and financials sectors, along with underweight allocations to healthcare and industrials. The fund remains optimistic about the long-term outlook for U.S. small-cap equities. Please review the Strategy's top five holdings to gain insights into their key selections for 2026. In its first-quarter 2026 investor letter, Aristotle Small Cap Equity Fund highlighted Envista Holdings Corporation (NYSE:NVST) as a newly added position. Envista Holdings Corporation (NYSE:NVST) is a leading dental products company, that develops and manufacturers a portfolio of implants, imaging systems, treatment software, and aligners. On May 20, 2026, Envista Holdings Corporation (NYSE:NVST) closed at $23.77 per share. One-month return of Envista Holdings Corporation (NYSE:NVST) was -12.09%, and its shares gained 40.90% over the past 52 weeks. Envista Holdings Corporation (NYSE:NVST) has a market capitalization of $3.87 billion. Aristotle Small Cap Equity Fund stated the following regarding Envista Holdings Corporation (NYSE:NVST) in its Q1 2026 investor letter: "Envista Holdings Corporation (NYSE:NVST) is a global manufacturer and marketer of dental consumables, equipment, diagnostics, orthodontic solutions, and treatment technologies, offering a comprehensive portfolio that includes implants, imaging systems, treatment software, and aligners. Dental care represents a structurally attractive, non-discretionary end market, supported by aging demographics, increasing oral health awareness, and sustained demand for restorative and aesthetic procedures. Through its broad product portfolio and service capabilities, the company offers exposure to a growing, recurring revenue dental market, with meaningful margin recovery potential as management executes on operational initiatives, at an attractive valuation." Envista Holdings Corporation (NYSE:NVST) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 36 hedge fund portfolios held Envista Holdings Corporation (NYSE:NVST) at the end of the fourth quarter, up from 29 in the previous quarter. In Q1 2026, Envista Holdings Corporation (NYSE:NVST) reported core revenue growth of 9.5%. While we acknowledge the risk and potential of Envista Holdings Corporation (NYSE:NVST) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Envista Holdings Corporation (NYSE:NVST) and that has 10,000% upside potential, check out our report about this cheapest AI stock. In another article, we covered Envista Holdings Corporation (NYSE:NVST) and shared Ariel Fund's insights on the company. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors. Disclosure: None. This article is originally published at Insider Monkey. Related Insider Monkey Articles
Envista announces participation in 8th Annual Evercore Healthcare Conference. BREA, Calif., Nov. 25, 2025 /PRNewswire/ - Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference. The fireside chat will take place on Wednesday, December 3, 2025, from 12:30 - 1:15 pm ET. A live audio webcast of the event, along with an archived replay, will be available in the Investors section of the Envista website athttps://investors.envistaco.com/. Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com. FOR FURTHER INFORMATION Jim Gustafson Vice President, Investor Relations Envista Holdings Corporation 200 S. Kraemer Blvd., Building E Brea, CA 92821 [emailprotected] SOURCE Envista Holdings Corporation